Gains all across the board for IBM

By: Miguel A. Rodriguez

15:11, 22 April 2021

1619092963.png
International Business Machines (IBM) reported first-quarter 2021 figures that came in better than estimated

The company revealed an adjusted EPS of $1.77 on revenues of $17.73 billion. The market was looking for an EPS of $1.63 and revenues of $17.35 billion. The latter grew 0.9% on an annualized basis in the quarter. It is the first time in four quarters when IBM reported revenue growth.

The company’s Global Technology Services segment, responsible for services, outsourcing and support, accounted for most of the quarter’s overall revenue - $6.37 billion. By the end of 2021, IMB plans to spin off part of the segment as a standalone company called Kyndryl. Even though it contributed the least to the overall revenue, the Systems segment, in charge of deals with mainframe computers and other hardware, grew 4% to $1.43 billion compared to the previous figures.

Moreover, IBM announced that it purchased 7Summits, Taos, two consulting firms, and cloud migrations in the quarter. Also, it sold 250 patents to Instacart.

IBM closed the Wednesday session 3.90% higher. Since the beginning of the year, its stock price went up around 6%, while USA500 gained almost 11%.

Sources: cnbc.com, reuters.com, finance.yahoo.com              

Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.

Most affected instruments

IBM

$ 10

USA500

$ 10